Literature DB >> 6703687

Mechanism of action of AC-1370 on phagocyte functions.

H Ohnishi, H Inaba, H Mochizuki, H Kosuzume.   

Abstract

The mechanism of action of a new semisynthetic cephalosporin AC-1370 on phagocyte functions was investigated. AC-1370 enhanced phagocytic functions of macrophages and neutrophils. AC-1370 bound to 27.4% of mouse peritoneal resident cells. Most of the AC-1370-binding cells were macrophages, and few neutrophils bound AC-1370. Culture supernatant of mouse macrophages cultured with AC-1370 significantly augmented phagocytic functions of mouse neutrophils. This activity of the culture supernatant of AC-1370-stimulated macrophages was abolished by digestion with trypsin but not by heat treatment at 56 degrees C for 30 min. The mechanism of the activation of phagocyte functions by AC-1370 is proposed as follows. First, AC-1370 binds to macrophages and causes their activation. Second, trypsin-sensitive and heat-stable soluble factor(s) is released from these macrophages. And finally, neutrophil functions are activated by the factor(s).

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6703687      PMCID: PMC185441          DOI: 10.1128/AAC.25.1.88

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  9 in total

1.  Immediate reactions in the skin of experimental animals provoked by antibody-antigen interaction.

Authors:  Z OVARY
Journal:  Prog Allergy       Date:  1958

2.  Bacteremia and fungemia complicating neoplastic disease. A study of 364 cases.

Authors:  C Singer; M H Kaplan; D Armstrong
Journal:  Am J Med       Date:  1977-05       Impact factor: 4.965

3.  Immunoglobulin (Ig) allotype markers on rabbit lymphocytes: separation of cells bearing different allotypes and demonstration of the binding of Ig to lymphoid cell membranes.

Authors:  P P Jones; J J Cebra; L A Herzenberg
Journal:  J Immunol       Date:  1973-11       Impact factor: 5.422

4.  Chromatographic purification of tetramethylrhodamine-immune globulin conjugates and their use in the cellular localization of rabbit gamma-globulin polypeptide chains.

Authors:  J J Cebra; G Goldstein
Journal:  J Immunol       Date:  1965-08       Impact factor: 5.422

Review 5.  Opportunistic infection: a review.

Authors:  A S Klainer; W R Beisel
Journal:  Am J Med Sci       Date:  1969-12       Impact factor: 2.378

6.  Effects of AC-1370, a new semisynthetic cephalosporin, on phagocyte functions.

Authors:  H Ohnishi; H Kosuzume; H Inaba; M Okura; H Mochizuki; Y Suzuki; R Fujii
Journal:  Antimicrob Agents Chemother       Date:  1983-06       Impact factor: 5.191

7.  Macrophage production of fibronectin, a chemoattractant for fibroblasts.

Authors:  Y Tsukamoto; W E Helsel; S M Wahl
Journal:  J Immunol       Date:  1981-08       Impact factor: 5.422

8.  Fibronectin is produced by human macrophages.

Authors:  K Alitalo; T Hovi; A Vaheri
Journal:  J Exp Med       Date:  1980-03-01       Impact factor: 14.307

9.  The relationship between surface immunoglobulin isotype and immune function of murine B lymphocytes. I. Surface immunoglobulin isotypes on primed B cells in the spleen.

Authors:  I Zan-Bar; S Strober; E S Vitetta
Journal:  J Exp Med       Date:  1977-05-01       Impact factor: 14.307

  9 in total
  7 in total

Review 1.  Effects of anti-infectious agents on polymorphonuclear neutrophils.

Authors:  M T Labro; J el Benna
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-02       Impact factor: 3.267

Review 2.  Immunomodulation by antibacterial agents. Is it clinically relevant?

Authors:  M T Labro
Journal:  Drugs       Date:  1993-03       Impact factor: 9.546

3.  Cefodizime host-defence enhancement: considerations of dose-response relationships in healthy volunteers.

Authors:  G Gialdroni Grassi; P M Shah
Journal:  Infection       Date:  1992       Impact factor: 3.553

4.  In vitro and in vivo antimycobacterial activities of a new quinolone, DU-6859a.

Authors:  H Saito; H Tomioka; K Sato; S Dekio
Journal:  Antimicrob Agents Chemother       Date:  1994-12       Impact factor: 5.191

5.  Tolerance and disposition of cefpimizole in normal human volunteers after intramuscular administration.

Authors:  E Novak; D B Lakings; L M Paxton
Journal:  Antimicrob Agents Chemother       Date:  1987-11       Impact factor: 5.191

6.  Differential stimulation of lymphocyte cell growth in vitro by cephalosporins.

Authors:  G Leyhausen; G Seibert; A Maidhof; W E Müller
Journal:  Antimicrob Agents Chemother       Date:  1984-11       Impact factor: 5.191

7.  Pharmacokinetics and dose proportionality of cefpimizole in normal humans after intramuscular administration.

Authors:  D B Lakings; E Novak; J M Friis; C M Lunan; L M Paxton
Journal:  Antimicrob Agents Chemother       Date:  1986-02       Impact factor: 5.191

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.